Comparison of the predictive value of ST segment elevation resolution at 90 and 180 min after start of streptokinase in acute myocardial infarction. A substudy of the Hirudin for Improvement of Thrombolysis (HIT)-4 Study

European Heart Journal

Volumn 20, Issue 21, 1999, Pages 1563-1571

  Schroder R ^a,b   Zeymer, U ^c   Wegscheider, K ^a,b   Neuhaus, K L ^c  

^a Co ordinating Ctr HIT 4 Trial ^*  (Germany)

^b Städtische Kliniken ^*  (Germany)

^c KLINIKUM KASSEL   (Germany)

Author keywords

Acute myocardial infarction; Prognosis; ST resolution at 180 min; ST resolution at 90 min

Indexed keywords

HIRUDIN; STREPTOKINASE;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOPLASTY; ARTICLE; BLOOD CLOT LYSIS; CAUSE OF DEATH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ELECTROCARDIOGRAM; FEMALE; HEART DEATH; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION; TREATMENT OUTCOME;

DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY; FIBRINOLYTIC AGENTS; HEART CONDUCTION SYSTEM; HIRUDIN THERAPY; HUMANS; MULTICENTER STUDIES; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS; RISK ASSESSMENT; STREPTOKINASE; SURVIVAL ANALYSIS; THROMBOLYTIC THERAPY; TIME FACTORS;

EID: 0345669124     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.1999.1664     Document Type: Article

References (20)

1. Schröder R, Dissmann R, Brüggemann T, Wegscheider K, Linderer T, Tebbe U. Extent of early ST segment elevation resolution: a simple but strong predictor of outcome in patients with acute myocardial infarction. J Am Coll Cardiol. 24:1994;384-391.
2. Schröder R, Wegscheider K, Schröder K, Dissmann R, Meyer-Sabellek W. Extent of early ST segment elevation resolution: a strong predictor of outcome in patients with acute myocardial infarction and a sensitive measure to compare thrombolytic regimens. A substudy of the International Joint Efficacy Comparison of Thrombolytics (INJECT) Trial. J Am Coll Cardiol. 26:1995;1657-1664.
3. Neuhaus KL, Molhoek P, Zeymer U. Recombinant Hirudin (Lepirudin) for the improvement of thrombolysis with streptokinase in patients with acute myocardial infarction: Results of the HIT-4 Trial. J Am Coll Cardiol. 34:1999;in press.
4. Zeymer U, Schröder R, Molhoek P, Tebbe U, Jessel A, Neuhaus KL. 90-min patency and 180-min resolution of ST-segment elevation are equally effective predictors of 30-day mortality after AMI (Abstr). Eur Heart J. 18:1997;325.
5. Fleiss J. Statistical methods for rates and proportions, 2nd edn. 1981;Wiley, New York. p. 61-7.
6. Lausen B, Schumacher M. Maximally selected rank statistics. Biometrics. 48:1992;73-85.
7. Granger CB, White HD, Bates ER, Ohman EM, Califf RM. A pooled analysis of coronary arterial patency and left ventricular function after intravenous thrombolysis for acute myocardial infarction. Am J Cardiol. 74:1994;1220-1228.
8. Simes RJ, Topol EJ, Holmes DR Jr. Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. Circulation. 91:1995;1923-1928.
9. Grines CL, Topol EJ, O'Neill WW. Effect of cigarette smoking on outcome after thrombolytic therapy for myocardial infarction. Circulation. 91:1995;298-303.
10. Zahger D, Cercek B, Cannon CP. How do smokers differ from nonsmokers in their response to thrombolysis? (The TIMI-4 Trial). Am J Cardiol. 75:1995;232-236.
11. Pacouret G, Charbonnier B, Curien ND. Invasive reperfusion study II. Multicentre European randomized trial of anistreplase vs streptokinase in acute myocardial infarction. Eur Heart J. 12:1991;179-185.
12. Anderson JL, Sorensen SG, Moreno FL. Multicenter patency trial of intravenous anistreplase compared with streptokinase in acute myocardial infarction. Circulation. 83:1991;126-140.
13. Granger CB, Califf RM, Young S. Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. J Am Coll Cardiol. 21:1993;920-925.
14. Woodfield SL, Lundergan CF, Reiner JA. Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction. The GUSTO-I Experience. J Am Coll Cardiol. 28:1996;1661-1669.
15. Krucoff MW, Croll MA, Granger CB. Continuous 12-lead ST-segment recovery analysis in the TAMI-7 Study. Circulation. 88:1993;437-446.
16. Somitsu Y, Nakamura M, Degawa T, Yamaguchi T. Prognostic value of slow resolution of ST-segment elevation following successful direct percutaneous transluminal coronary angioplasty for recovery of left ventricular function. Am J Cardiol. 80:1997;406-410.
17. van't Hof A, Liem A, de Boer M-J, Zijlstra F. Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction. Lancet. 350:1997;615-619.
18. Muller JE, Maroko PR, Braunwald E. Precordial electrocardiographic mapping: a technique to assess the efficacy of interventions designed to limit infarct size. Circulation. 57:1978;1-18.
19. Kenner MD, Zajac EJ, Kondos GT. Ability of the no-flow phenomenon during an acute myocardial infarction to predict left ventricular dysfunction at one-month follow-up. Am J Cardiol. 76:1995;861-868.
20. Ito H, Maruyama A, Iwakura K. Clinical implications of the 'no-reflow' phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation. 93:1996;223-228.